IOL Chemicals And PharmaceuticalsNSE:IOLCP +2.06%68 Interest Coverage is 22.56 as of Mar. 2026, which is 59% above its 10-year median of 14.23. GuruFocus rates NSE:IOLCP with a GF Score™ of 68/100 and a GF Value™ of ₹93.62 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 685 Drug Manufacturers companies, IOL Chemicals And Pharmaceuticals ranks better than 50.36% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. IOL Chemicals And Pharmaceuticals's
Operating Income
for the
three
months ended in Mar. 2026 was ₹722 Mil. IOL Chemicals And Pharmaceuticals's Interest Expense for the
three
months ended in Mar. 2026 was ₹-32 Mil.
IOL Chemicals And Pharmaceuticals's interest coverage for the quarter that ended in Mar. 2026 was 22.56.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for IOL Chemicals And Pharmaceuticals's Interest Coverage or its related term are showing as below:
NSE:IOLCP'
s Interest Coverage Range Over the Past 10 Years
Min: 1.17 Med: 14.23 Max: 588.45
Current: 12.97
NSE:IOLCP's Interest Coverage is ranked better than 50.36% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.78
vs NSE:IOLCP: 12.97
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
IOL Chemicals And Pharmaceuticals Interest Coverage Related Terms
IOL Chemicals And Pharmaceuticals Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
IOL Chemicals And Pharmaceuticals Interest Coverage Chart
For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IOL Chemicals And Pharmaceuticals Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's Interest Coverage distribution charts can be found below:
* The bar in red indicates where IOL Chemicals And Pharmaceuticals's Interest Coverage falls into.
IOL Chemicals And Pharmaceuticals Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a Interest Coverage of 22.56 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. This is 59% above median its historical median of 14.23. Over the past decade, IOL Chemicals And Pharmaceuticals' Interest Coverage has ranged from 1.17 to 588.45. According to the industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #340 out of 685 companies in the Drug Manufacturers industry, placing it in the top 49.6%.
Is IOL Chemicals And Pharmaceuticals' Interest Coverage too high?
IOL Chemicals And Pharmaceuticals' current Interest Coverage of 22.56 is 59% above median its 10-year median of 14.23. Over the past 10 years, this metric has ranged from a low of 1.17 to a high of 588.45. The Drug Manufacturers industry median Interest Coverage is 12.78. IOL Chemicals And Pharmaceuticals' value of 22.56 is 76.5% above this industry median. Based on the distribution chart, IOL Chemicals And Pharmaceuticals ranks #340 out of 685 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #340 out of 685 companies for Interest Coverage. This puts IOL Chemicals And Pharmaceuticals in the upper half of its industry. The industry median Interest Coverage is 12.78. IOL Chemicals And Pharmaceuticals' value of 22.56 is 76.5% above this benchmark. Historically, IOL Chemicals And Pharmaceuticals' own Interest Coverage has ranged from 1.17 to 588.45 over the past decade. While the company's 10-year median is 14.23 vs. the industry median of 12.78, IOL Chemicals And Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.78, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IOL Chemicals And Pharmaceuticals's current Interest Coverage of 22.56 is 76.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IOL Chemicals And Pharmaceuticals's current Interest Coverage is 22.56, which is 59% above median its own 10-year median of 14.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹93.62, compared to a current price of ₹133.66 — trading 42.8% above its estimated fair value. The current Interest Coverage is 22.56, which is 59% above median its 10-year median of 14.23 and 76.5% above the Drug Manufacturers industry median of 12.78. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current Interest Coverage is 22.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹133.66 is trading 42.8% above its estimated GF Value™ of ₹93.62.
GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for NSE:IOLCP:
Interest Coverage: 22.56 (59% above median its 10-year median of 14.23)
GF Value™: ₹93.62 vs. price of ₹133.66 (42.8% above fair value)
Industry Position: 76.5% above the Drug Manufacturers median (#340 of 685)
No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IOL Chemicals And Pharmaceuticals Business Description
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
68GF Score
Get the complete analysis for NSE:IOLCP
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:IOLCP has been successfully added to your 
